B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. - Wikidata - awgldk - TriplyDB

B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.

B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.

http://www.wikidata.org/entity/Q34781487

about

Type I interferon blockade in systemic lupus erythematosus: where do we stand?Intracellular nucleic acid sensors and autoimmunity Modelling clinical systemic lupus erythematosus: similarities, differences and success stories Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.Cytokine disturbances in systemic lupus erythematosus.Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus.The discovery and development of belimumab: the anti-BLyS-lupus connection Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice.Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE).Epidermal injury promotes nephritis flare in lupus-prone mice.Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed mice Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.IFNα Inducible Models of Murine SLE.Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.Biologic differences between various inhibitors of the BLyS/BAFF pathway: should we expect differences between belimumab and other inhibitors in development?B-lymphocyte signalling abnormalities and lupus immunopathology.Future prospects in biologic therapy for systemic lupus erythematosus.Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus.B cells biology in systemic lupus erythematosus-from bench to bedside.Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.HIV-1-Mediated BAFF Secretion in Macrophages Does Not Require Endosomal TLRs, Type-I IFN, and Nef, but Depends on the Cellular Phenotype Status.Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes

P2860

Q26865441-E4BACBD2-F488-46A2-B713-2273A3831567 Q26997316-B911E89A-272D-4C46-A05A-D3E11B3EF837 Q28074217-8A27061E-46D0-4093-A9D9-50B37F6DA272 Q30410652-AA212F94-987F-46C6-B2F8-498752713DFC Q34960458-35698EE0-D927-44DF-8EF9-F00ECDC1B6B9 Q35617573-A291CAEF-A010-4C5E-BA61-930696BB4252 Q35674006-313E11AE-633A-425B-B7EA-F05F9E880C0C Q35686263-862E8F65-A08C-456D-81C1-643A74DFE76E Q35691272-1CF928E7-9026-42E7-836A-C9E9DE4D5F89 Q35798968-5915874D-4068-4CBA-B891-AFAE8CF64338 Q36271212-6ED00359-1FB3-48B0-90FE-C8F6F4AAEA66 Q36373291-C3AA1458-71C4-4C1A-AA14-349509933679 Q36490737-8943A036-18C1-4130-85A0-4B1113893668 Q36745567-3FB2CC19-4BFF-4896-8E31-8749219D8E15 Q36745815-886BFD02-1AFC-45A8-909B-B4D523F56978 Q37210594-CBC7499E-0FF2-4DD4-80DA-29A8771BB6CD Q37709763-53F3ACE7-391E-4CB7-AB18-642E0ACCB59A Q37737549-97BE04DD-3F61-4947-BE4A-046E9DC50300 Q38006643-D9BFEC76-6496-49A1-8C6F-17E433FAC187 Q38114500-11EEB81C-9E68-4AA3-8D8E-83B9F22860FF Q38135706-C47D9927-F43E-4913-A94F-B8C467A2DFF8 Q38187489-5200E820-C556-41E4-9713-91E3E472F60C Q38631964-7D840D70-A429-41AB-A69D-BA70FBCD2665 Q38735507-A3093456-7577-46CF-88E3-88F35232C586 Q39027389-5B370AAD-EAA2-4E32-AC6E-74395AB71640 Q42737499-6C31BE30-4D35-4247-B745-399352F9E4F3 Q46536956-30338DD4-B088-4798-BEC5-C871830253AC Q53618640-7A105BFC-2874-4381-914D-14AB8B410F99 Q58122908-FDB5C943-BCED-4D22-9D0E-60EB4E5E1D01

P2860

B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.

http://www.wikidata.org/entity/Q34781487

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@ast

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@en

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@nl

type

label

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@ast

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@en

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@nl

prefLabel

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@ast

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@en

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@nl

P1433

Q34781487-AF9FD997-41D6-40E0-9CDC-AAD7C0168426

P1476

Q34781487-B596C95C-7194-4681-89FB-909D1158E794

P2093

Q34781487-048F8701-947E-4C23-8FA0-E3BFC351F78F

Q34781487-1CB32E83-8367-4703-9D2C-A819F63E3169

Q34781487-64E08914-A300-4572-90B5-D36811434643

Q34781487-73369EBB-38E9-4D4A-986A-EC247E9F3514

Q34781487-89C51167-DECD-441F-A7DF-5BEA5490C9CA

Q34781487-AD8829EB-E442-4F7F-B285-314F239E4774

Q34781487-E569939B-5330-4DF9-8A6A-2A40EADD9630

Q34781487-EEE3018F-7DB5-435E-9DA9-F3D851160762

P2860

Q34781487-0569BF3C-86EE-4B67-A96D-60563CEE12D2

Q34781487-0931BAC4-E41B-4FA0-9535-38F06C368C41

Q34781487-09FB58BD-8FD9-4284-8D6B-847D161FB91C

Q34781487-109D1B66-8D77-430E-9E1B-4EE3473D9EF9

Q34781487-1111DF9F-A3B4-4B24-8DFE-DC566DDDB9D0

Q34781487-1131A683-E25E-4FDA-86D6-CCC28AE13F97

Q34781487-17921C5A-D7AE-45FC-9615-CD16B6291344

Q34781487-1D09FDBC-9CAA-4BFE-A4AB-4C8962D86A2A

Q34781487-27038125-303A-4057-B858-C50F4A2EDAFD

Q34781487-2C2E3147-9FB8-46CF-AA7B-EE8AE2DC4495

P304

Q34781487-CB93C2CF-07B0-47C1-A791-0770F52225DE

P31

Q34781487-EFB13A6F-DB98-4478-A1FD-C1CC40817EDF

P356

Q34781487-959ECEEF-AFD0-46BC-9D81-86AD7B3D8A99

P407

Q34781487-8028A928-4E0C-475E-8394-44298DB21D14

P433

Q34781487-207DEBB3-6D81-490D-8A13-E646CD3C7E59

P478

Q34781487-27A154E3-9B1E-449A-AEC9-BFC9489CBD73

P577

Q34781487-2B3CD370-8A2C-41E7-AECC-9E10304F803A

P5875

Q34781487-D7B7D5FB-6014-4B22-802F-8418CCDC89D0

P698

Q34781487-B27C7ED7-829C-451D-8863-8DAFFBA91965

P932

Q34781487-A2EAD1BD-A3C7-4772-8AEE-EDCDFB718722

P356

JIMMUNOL.1000466

P1433

Journal of Immunology

P1476

B Cell and BAFF dependence of ...... hematosus-prone NZM 2328 mice.

@en

P2093

Alexis Mathian

http://www.w3.org/2001/XMLSchema#string

Chaim O Jacob

http://www.w3.org/2001/XMLSchema#string

Chaim Putterman

http://www.w3.org/2001/XMLSchema#string

Michael N Koss

http://www.w3.org/2001/XMLSchema#string

Noam Jacob

http://www.w3.org/2001/XMLSchema#string

Shunhua Guo

http://www.w3.org/2001/XMLSchema#string

Simona Gindea

http://www.w3.org/2001/XMLSchema#string

William Stohl

http://www.w3.org/2001/XMLSchema#string

P2860

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.

P304

4984-4993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1000466

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50304381

http://www.w3.org/2001/XMLSchema#string

P698

21383240

http://www.w3.org/2001/XMLSchema#string

P932

3074466

http://www.w3.org/2001/XMLSchema#string